Blue Horseshoe Stocks: Eye-Popping Profits Pouring In!

Canopy Growth Corp. CGC

It’s been just under two weeks since we alerted readers that we were interested in the CGC 09/21 $30-40 Calls. This was as a direct result of beverage behemoth Constellation Brands’ (STZ) adding a multi-billion dollar block to its stake in CGC.

CGC shares themselves have risen 66% over the same period, from a low of 29.05 to yesterday’s new high of 48.19.

What this continued bullish surge has done for our options ideas has been nothing short of eye-popping. The update ranges and total possible gains so far are as follows:

$30 Calls – Range: 1.76-18.20 – Max Gain: 934%
$35 Calls – Range: .56-13.90 – Max Gain: 2382%
$40 Calls – Range: .16-8.75 – Max Gain: 5369%

The $40′s especially have obliterated our wildest expectations. A paltry $16 investment on a single $40 Call contract at the lows, would have been been worth roughly $859 at the highs!


FRESH IDEAS

As you can very plainly see, options are where the biggest potential profits lie, so we will of course be offering up a couple of fresh ideas this morning.

Both TIF and DSW are coming off of good receptions in the wake of their quarterly earnings reports today. We’ll take that into account and keep the following plays on watch:

Tiffany & Co. TIF Weekly $136-140 Calls
DSW, Inc. DSW 09/21 $30-35 Calls


Extended Watchlist:
RGSE, EGLT, MARA, CDXS, ECR, STAF, NEPT, CHFS

Blue Horseshoe Stocks: Options Review

Tiffany & Co. TIF – Options Recap
We wanted to take an opportunity to backtrack to our options idea from Wednesday, the TIF Weekly $114-117 Calls. We caught the stock on the heels of its earnings report, and the subsequent activity allowed for a good chance for us at the top of that range.

Our ideas got pushed so deep in the money, that the big winner turned out to be the 117′s. Those contracts started out on Wednesday from a low of 1.53, and as of yesterday had reached an impressive high of 8.24. That works out to a two-day swing of 439%


Footlocker, Inc. FL 

We’ve had some good luck with the FL options chain in the past, and we’re going to place some contracts on watch today in the wake of the company’s big profit and sales beat this morning. Q1 earnings blew people away today, and as a result the stock is up considerably.

With no weekly expiration contracts available, we’re going to go out to the FL 06/15 $52.50-55 Calls, for potential quick strike trades.


Extended Watchlist:
QUIK, CDTX, CLWT, AVGR, OHGI, AVGR, PRPO

Incoming search terms:

  • ropes3s

Blue Horseshoe Stocks: TJX Recap & More

The TJX Companies, Inc. TJX – Options Recap

TJX found its way to our premarket report yesterday morning, after the company posted a solid quarterly release.

To coincide with the activity we were observing, we slated a range of options ideas to keep track of, the TJX 06/15 $85-90 Calls. We are pleased to report that there were some nice gains available to traders before noon.

$85 Calls – Range: 2.14-3.90 – Max Gain: 214%
$87.50 Calls – Range: .90-2.50 – Max Gain: 178%
$90 Calls – Range: .35-1.10 – Max Gain: 214%
________

Fresh Options Ideas:
Tiffany & Co. TIF Weekly $114-117 Calls
Lowes Companies, Inc. LOW Weekly $88-90 Calls


Other Updates

Each of the following have been picks we’ve included in our daily reports from roughly the last month or so. We have included our alert date, observed lows, and subsequent highs along with the total possible gains that were on the table.

ARQL (04/18) 2.40-4.20, +75%
SDR (05/18) 1.26-1.74, +38%
HTBX (05/14) 1.35-2.00, +48%


Extended Watchlist:
TRXC, AVGR, SNES, DPW, ADOM, AEL

Blue Horseshoe Stocks: KOOL, TIF Recaps & More

Endocyte, Inc. ECYT

We initially took notice of ECYT on Monday morning just as the company announced it had completed a worldwide license for its prostate cancer treatment now moving into Phase-3 development.

The stock made a solid 130% rip from 1.63 to 3.75 that morning, but it was only just getting started. Yesterday morning the stock ran hard once again, reaching its peak at a new annual high of 6.55. That puts the total on our two-day observed increased of 302% while volume over the same period has been literally hundreds of times greater than the monthly average prior to Monday’s bombshell PR.


Tiffany & Co. TIF – Options Update

As we were just mentioning yesterday morning, we’ve been tracking the TIF 10/20 $92-93 Calls since the morning of September 28th. TIF stock has maintained its gradual ascent since that time, and with that, we’ve seen the potential gains made off of our ideas grow along with it.

The following ranges represent the lows from the 28th to the highs achieved during yesterday’s session:

$92 Calls – Range: 1.00-2.20 – Max Gain: 120%
$92.50 Calls – Range: .85-2.19  – Max Gain: 158%.
$93 Calls – Range: .83-2.15 – Max Gain: 159%


Cesca Therapeutics Inc. KOOL

After including KOOL in yesterday morning’s watchlist, we watched as the stock made a very nice intraday run on the chart with the help of some positive news.

The U.S. Patent and Trademark Office issued a Notice of Allowance on the company’s patent application for its proprietary method for separating target cells from blood, marrow, and other sources.

That prompted a solid boost from 3.96 to 6.44 on the day, marking an intraday push of 63% which was accompanied by the trading of 223X more shares than the monthly average!


Extended Watchlist:
CATB, RGSE, CAPR, ATNM, VKTX, MNKD, BIOP,  HTBX

Blue Horseshoe Stocks: ECYT Recap & More

Endocyte, Inc. ECYT

We took notice of ECYT yesterday morning during our routine premarket scan, and due to some abnormal activity, we decided to include it in the daily watchlist.

It turned out to be a splendid idea, with the stock ultimately recording a hugely bullish session. ECYT traded from its low of 1.63 just following the open, to its high of 3.75 just prior to the close. It worked out to a single-session rip of 130% and it came on over 180X the monthly average volume. The stock has also hit a new high of 6.07 in the premarket this morning, pushing our observed move in less than 24 hours to a whopping 272%

It was especially impressive because of the timing, which couldn’t have been any better. Prior to yesterday’s session the stock was stagnating for several months. The move was catalyzed primarily by the announcement of the completion of a worldwide license on the company’s prostate cancer treatment, which will be moving on to Phase III development. (>>View PR)


Rigel Pharmaceuticals, Inc. RIGL

Speaking of solidly-timed calls on pharma plays, we also caught RIGL and included it in yesterday’s premarket report. It didn’t see the type of move that the previously mentioned stock, but got off to a respectable start.

RIGL traded in a range from 2.85-3.42, a modest rise of 20%, but did so on nearly 17X the monthly average volume, and closed near its high of day. We’ll continue to observe this play to see if it can establish a sustained uptrend.


Capricor Therapeutics, Inc. CAPR

We were just updating our readers yesterday morning on the moves CAPR had made since we had alerted it onSeptember 20th from its low of 1.80.

What followed was another nice session for the stock, which ran to a new high of 4.25; a total increase of 136% in a span of just eight trading days.



Tiffany & Co. TIF – Options Update

We also want to quickly update readers on our TIF options ideas that we submitted on the morning of September 28th, the TIF 10/20 $92-93 Calls. The stock has been in a continuous bullish pattern since then, and those calls made some pretty nice gains in the process.

$92 Calls – Range: 1.00-2.13 – Max Gain: 113%
$92.50 Calls – Range: .85-1.74  – Max Gain: 105%.
$93 Calls – Range: .83-1.88 – Max Gain: 127%


Extended Watchlist:
ETRM, VICL, DMPI, TA, KOOL, CATB